Pathway analysis showed that multiple cancers and related signaling pathways (such as renal cell carcinoma, thyroid cancer and HIF-signaling pathway) correlated with METTL3-mediated m6A modification (Additional file 5: Figure S2b). Here, METTL3 is linked to thyroid cancer.